Patent Assignment
Reel/Frame 016100/0749
Assignment of Assignor's Interest
Recorded: 2005-06-07
Pages: 4
Assignor
TAPESTRY PHARMACEUTICALS, INC.
Executed: 2005-04-25
Assignee
INVITROGEN CORPORATION
1600 FARADAY AVENUE, CARLSBAD, CALIFORNIA, 92008
Covered Properties
(2)
Locked Nucleic Acid Hybrids and Methods of Use
Dna Hybrids Stabilized by Heterologies: Inverse Stringency Homologous Gene Targeting
Application:
60/130,345 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 20, 2000
From: BELOTSERKOVSKII, BORIS P.; REDDY, GURUCHARAN; ZARLING, DAVID A.
To: PANGENE CORPORATION
Reel/Frame 011316/0169 →
Assignment of Assignor's Interest
Jan 24, 2003
From: PANGENE CORPORATION
To: NAPRO BIO THERAPEUTICS, INC.
Reel/Frame 013697/0960 →
Merger
Oct 14, 2004
From: NAPRO BIOTHERAPEUTICS, INC.
To: TAPESTRY PHARMACEUTICALS, INC.
Reel/Frame 015247/0597 →
Merger
Feb 3, 2010
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 023882/0551 →
Corrective Assignment to Correct the Application No 09452626 Previously Recorded on Reel 023882 Frame 0551. Assignor(S) Hereby Confirms the Merger Should Not Have Been Recorded Against This Patent Application Number.
Nov 14, 2014
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 034217/0490 →